Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08DOG
|
||||
Former ID |
DNC008970
|
||||
Drug Name |
A-846714
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C16H18N6
|
||||
Canonical SMILES |
CN1CCN(CC1)C2=NC(=NC(=C2)C3=CC=C(C=C3)C#N)N
|
||||
InChI |
1S/C16H18N6/c1-21-6-8-22(9-7-21)15-10-14(19-16(18)20-15)13-4-2-12(11-17)3-5-13/h2-5,10H,6-9H2,1H3,(H2,18,19,20)
|
||||
InChIKey |
QFKQUMBUFVKQBH-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Histamine H4 receptor | Target Info | Inhibitor | [1] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
Reactome | Histamine receptors | ||||
G alpha (i) signalling events | |||||
WikiPathways | GPCR ligand binding | ||||
GPCR downstream signaling | |||||
GPCRs, Other | |||||
References | |||||
REF 1 | J Med Chem. 2008 Oct 23;51(20):6547-57. Epub 2008 Sep 26.Rotationally constrained 2,4-diamino-5,6-disubstituted pyrimidines: a new class of histamine H4 receptor antagonists with improved druglikeness and in vivo efficacy in pain and inflammation models. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.